Nautilus Biotechnology to Announce Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021
July 13, 2021 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, July 13, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the...
Nautilus Biotechnology Appoints Emma Lundberg, Ph.D., to Scientific Advisory Board
June 17, 2021 07:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, June 17, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome
June 09, 2021 22:05 ET
|
Nautilus Biotechnology Inc.
Business combination transaction with Arya Sciences Acquisition Corp III, a special purpose acquisition company sponsored by Perceptive Advisors, closed on June 9, 2021Publicly traded company renamed...